Also provided are {HEAD ~ methods} to identify {TAIL ~ compositions} capable of treating cholesterol related disease states, comprising a. contacting a test composition with Na/K ATPase; and b. identifying if step a. results in antagonizing the ability of cholesterol to bind to the CRAC domain of the α1 subunit of Na/K ATPase 
Also provided are { HEAD ~ methods } to identify { TAIL ~ compositions } capable of treating cholesterol related disease states , comprising a. contacting a test composition with Na / K ATPase ; and b. identifying if step a. results in antagonizing the ability of cholesterol to bind to the CRAC domain of the α1 subunit of Na / K ATPase
OTH OTH OTH HEAD HEAD HEAD HEAD HEAD REL REL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH